Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Malaise, Muscle spasms, Pain, SARS-CoV-2 test
Clinical narrative: blood pressure was 223/170; severe cramps; jabbing/Woke up still in pain, not as severe; wasn't feeling good; COVID-19 symptoms began; the day after, had pain due to  abscessed tooth; left side was worse; lip was over chin; face swelled up; hives; she was bit by a brown recluse spider; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (blood pressure was 223/170) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033B21A / 083B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jul-2021, the patient experienced TOOTH ABSCESS (the day after, had pain due to  abscessed tooth), TOOTHACHE (left side was worse), LIP SWELLING (lip was over chin) and SWELLING FACE (face swelled up). In July 2021, the patient experienced URTICARIA (hives) and ARTHROPOD BITE (she was bit by a brown recluse spider). On 01-Aug-2021, the patient experienced COVID-19 (COVID-19 symptoms began). On 02-Aug-2021, the patient experienced MALAISE (wasn't feeling good). On 16-Nov-2021, the patient experienced HYPERTENSION (blood pressure was 223/170) (seriousness criterion hospitalization). On 18-Nov-2021, the patient experienced MUSCLE SPASMS (severe cramps) and PAIN (jabbing/Woke up still in pain, not as severe). The patient was hospitalized on 16-Nov-2021 due to HYPERTENSION. The patient was treated with CLINDAMYCIN on 08-Jul-2021 for Tooth abscess, at an unspecified dose and frequency; SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM) on 08-Jul-2021 for Tooth abscess, at an unspecified dose and frequency and LISINOPRIL ongoing from 16-Nov-2021 for Blood pressure high, at an unspecified dose and frequency. At the time of the report, HYPERTENSION (blood pressure was 223/170), TOOTH ABSCESS (the day after, had pain due to  abscessed tooth), TOOTHACHE (left side was worse), LIP SWELLING (lip was over chin), SWELLING FACE (face swelled up), MUSCLE SPASMS (severe cramps), PAIN (jabbing/Woke up still in pain, not as severe), MALAISE (wasn't feeling good), COVID-19 (COVID-19 symptoms began), URTICARIA (hives) and ARTHROPOD BITE (she was bit by a brown recluse spider) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Aug-2021, SARS-CoV-2 test: positive (Positive) COVID-19 virus test was positive. In September 2021, Heart rate: 38-40 (Low) pulse rate was 38-40 bpm. On 16-Nov-2021, Blood pressure measurement: 223/170 (High) blood pressure was high (223/170).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Patient was bit by a brown recluse spider. Went to ER and got a tetanus shot and doctor stated antibiotic that the patient was on, will cover. Had severe reaction 3 days after where she experienced hives. Doctor advised not get the second vaccine. Through the month, pulse was 38-40 bpm. Stayed in bed. She has been feeling better.  Company comment: This case concerns a 57-year-old, female patient with no medical history, who experienced the unexpected event of hypertension which required hospitalization and non serious event of COVID 19 along with other non serious events. The event of COVID 19 occurred approximately 25 day after the first dose of mRNA-1273 while event of hypertension occurred approximately five months and 9 days after the first dose. The rechallenge was not applicable as the outcome of events was unknown and since no information about the second dose was disclosed. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This case concerns a 57-year-old, female patient with no medical history, who experienced the unexpected event of hypertension which required hospitalization and non serious event of COVID 19 along with other non serious events. The event of COVID 19 occurred approximately 25 day after the first dose of mRNA-1273 while event of hypertension occurred approximately five months and 9 days after the first dose. The rechallenge was not applicable as the outcome of events was unknown and since no information about the second dose was disclosed. The benefit-risk relationship of mRNA-1273 is not affected by this report.